Aktuelle Fragen des med.-wiss. Publikationswesens (Teil 3)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119]

Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

Bibliographie

  1. ↑ Medical journal editing: who shall pay? Ann Intern Med 151(1):68-9 (2009) PMID 19581649
  2. ↑ ACP Journal Club. What kind of randomized trials do patients and clinicians need? Ann Intern Med 150(10):JC5-2, JC5-3 (2009) PMID 19451559
  3. ↑ ACP Journal Club. Interpreting meta-analyses in systematic reviews. Ann Intern Med 150(4):JC2-2, JC2-3 (2009) PMID 19238601
  4. ↑ The science and art of deduction: complex systematic overviews. Ann Intern Med 148(10):786-8 (2008) PMID 18490692
  5. ↑ Using existing systematic reviews in complex systematic reviews. Ann Intern Med 148(10):776-82 (2008) PMID 18490690
  6. ↑ How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 147(4):224-33 (2007) PMID 17638714
  7. ↑ Clinical trial registration: looking back and moving ahead. Ann Intern Med 147(4):275-7 (2007) PMID 17548404
  8. ↑ Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 146(12):878-81 (2007) PMID 17577007
  9. ↑ Institutional review board review of multicenter studies. Ann Intern Med 146(10):759 (2007) PMID 17502642
  10. ↑ Career changes in medicine: Part II. Ann Intern Med 145(10):782-3 (2006) PMID 17116924
  11. ↑ Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med 145(4):284-93 (2006) PMID 16908919
  12. ↑ Research misconduct, retraction, and cleansing the medical literature: lessons from the Poehlman case. Ann Intern Med 144(8):609-13 (2006) PMID 16522625
  13. ↑ Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Ann Intern Med 143(2):146-8 (2005) PMID 16027458
  14. ↑ Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 141(10):781-8 (2004) PMID 15545678
  15. ↑ Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 141(6):477-8 (2004) PMID 15355883
  16. ↑ Peer review: integral to Science and indispensable to Annals. Ann Intern Med 139(12):1038-40 (2003) PMID 14678925
  17. ↑ The cost of institutional review board procedures in multicenter observational research. Ann Intern Med 139(1):77 (2003) PMID 12834327
  18. ↑ Reflections on medical journals: has progress made them better? Ann Intern Med 137(1):46-8 (2002) PMID 12093244
  19. ↑ Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137(1):10-6 (2002) PMID 12093240
  20. ↑ Paying research subjects: an analysis of current policies. Ann Intern Med 136(5):368-73 (2002) PMID 11874309
  21. ↑ Core safeguards for clinical research with adults who are unable to consent. Ann Intern Med 135(7):514-23 (2001) PMID 11578155
  22. ↑ Sponsorship, authorship, and accountability. Ann Intern Med 135(6):463-6 (2001) PMID 11560460
  23. ↑ The Cochrane Collaboration. Ann Intern Med 135(4):309-12 (2001) PMID 11511165
  24. ↑ Adjustments for center in multicenter studies: an overview. Ann Intern Med 135(2):112-23 (2001) PMID 11453711
  25. ↑ Who is a peer? Ann Intern Med 134(4):346-7 (2001) PMID 11182858
  26. ↑ Reporting standards and the transparency of trials. Ann Intern Med 134(2):169-72 (2001) PMID 11177328
  27. ↑ Institutional review boards: a crisis in confidence. Ann Intern Med 134(2):161-3 (2001) PMID 11177321
  28. ↑ Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med 134(2):152-7 (2001) PMID 11177319
  29. ↑ Authors, editors, and readers in the brave new (electronic) world. Ann Intern Med 134(1):78 (2001) PMID 11187424
  30. ↑ Young physician-scientists: internal Medicine's challenge. Ann Intern Med 133(10):831-2 (2000) PMID 11085847
  31. ↑ News from the International Committee of Medical Journal Editors. Ann Intern Med 133(3):229-31 (2000) PMID 10906840
  32. ↑ The medical review article revisited: has the science improved? Ann Intern Med 131(12):947-51 (1999) PMID 10610646
  33. ↑ Fire ant attacks on residents in health care facilities: a report of two cases. Ann Intern Med 131(6):424-9 (1999) PMID 10498558
  34. ↑ Medical Writings revisited. Ann Intern Med 131(5):389-90 (1999) PMID 10475893
  35. ↑ Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med 130(12):1005-13 (1999) PMID 10383350
  36. ↑ Care at the end of life: guiding practice where there are no easy answers. Ann Intern Med 130(9):772-4 (1999) PMID 10357697
  37. ↑ Disclosure of researcher contributions: a study of original research articles in The Lancet. Ann Intern Med 130(8):661-70 (1999) PMID 10215563
  38. ↑ Masking, blinding, and peer review. Ann Intern Med 129(2):165 (1998) PMID 9669986
  39. ↑ Ethics manual. Fourth edition. American College of Physicians. Ann Intern Med 128(7):576-94 (1998) PMID 9518406
  40. ↑ Masking, blinding, and peer review: the blind leading the blinded. Ann Intern Med 128(1):66-8 (1998) PMID 9424984
  41. ↑ Integrating heterogeneous pieces of evidence in systematic reviews. Ann Intern Med 127(11):989-95 (1997) PMID 9412305
  42. ↑ Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-6 (1997) PMID 9382404
  43. ↑ Selecting and appraising studies for a systematic review. Ann Intern Med 127(7):531-7 (1997) PMID 9313021
  44. ↑ Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 127(5):380-7 (1997) PMID 9273830
  45. ↑ The relation between systematic reviews and practice guidelines. Ann Intern Med 127(3):210-6 (1997) PMID 9245227
  46. ↑ How consumers and policymakers can use systematic reviews for decision making. Ann Intern Med 127(1):37-42 (1997) PMID 9214251
  47. ↑ Using systematic reviews in clinical education. Ann Intern Med 126(11):886-91 (1997) PMID 9163290
  48. ↑ Locating and appraising systematic reviews. Ann Intern Med 126(7):532-8 (1997) PMID 9092319
  49. ↑ Systematic reviews: critical links in the great chain of evidence. Ann Intern Med 126(5):389-91 (1997) PMID 9054284
  50. ↑ Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 126(5):376-80 (1997) PMID 9054282
  51. ↑ Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment. Ann Intern Med 125(12):990-1000 (1996) PMID 8967711
  52. ↑ Megatrials for clinical decision making. Ann Intern Med 125(7):621; author reply 621-2 (1996) PMID 8815765
  53. ↑ Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125(7):605-13 (1996) PMID 8815760
  54. ↑ Does editorial peer review work? Ann Intern Med 121(1):60-1 (1994) PMID 8198351
  55. ↑ Medical treatment for stroke prevention. Ann Intern Med 121(1):41-53 (1994) PMID 7880225
  56. ↑ Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 120(8):667-76 (1994) PMID 8135452
  57. ↑ New international ethical guidelines for research involving human subjects. Ann Intern Med 119(4):339-41 (1993) PMID 8328746
  58. ↑ Conflict of interest. International Committee of Medical Journal Editors. Ann Intern Med 118(8):646-7 (1993) PMID 8452334
  59. ↑ Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 301(13):1367-72 (2009) PMID 19336712
  60. ↑ Internet-based learning in the health professions: a meta-analysis. JAMA 300(10):1181-96 (2008) PMID 18780847
  61. ↑ Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA 299(15):1813-7 (2008) PMID 18413875
  62. ↑ Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 299(15):1800-12 (2008) PMID 18413874
  63. ↑ Issues in the registration of clinical trials. JAMA 297(19):2112-20 (2007) PMID 17507347
  64. ↑ Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 297(11):1233-40 (2007) PMID 17374817
  65. ↑ How conducting a clinical trial affects physicians' guideline adherence and drug preferences. JAMA 295(23):2759-64 (2006) PMID 16788131
  66. ↑ Second-order peer review of the medical literature for clinical practitioners. JAMA 295(15):1801-8 (2006) PMID 16622142
  67. ↑ Effect of blinded peer review on abstract acceptance. JAMA 295(14):1675-80 (2006) PMID 16609089
  68. ↑ Transition from meeting abstract to full-length journal article for randomized controlled trials. JAMA 295(11):1281-7 (2006) PMID 16537738
  69. ↑ Medical treatment of peripheral arterial disease. JAMA 295(5):547-53 (2006) PMID 16449620
  70. ↑ Differences in review quality and recommendations for publication between peer reviewers suggested by authors or by editors. JAMA 295(3):314-7 (2006) PMID 16418467
  71. ↑ Randomized trials stopped early for benefit: a systematic review. JAMA 294(17):2203-9 (2005) PMID 16264162
  72. ↑ Relative citation impact of various study designs in the health sciences. JAMA 293(19):2362-6 (2005) PMID 15900006
  73. ↑ Digital information archiving policies in high-impact medical and scientific periodicals. JAMA 292(22):2724-6 (2004) PMID 15585731
  74. ↑ Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 292(17):2130-40 (2004) PMID 15523074
  75. ↑ Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms. JAMA 292(1):86-8 (2004) PMID 15238595
  76. ↑ Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291(20):2457-65 (2004) PMID 15161896
  77. ↑ Different patterns of duplicate publication: an analysis of articles used in systematic reviews. JAMA 291(8):974-80 (2004) PMID 14982913
  78. ↑ NIH peer review of grant applications for clinical research. JAMA 291(7):836-43 (2004) PMID 14970062
  79. ↑ Comparison between impact factors and citations in evidence-based practice guidelines. JAMA 290(6):755-6 (2003) PMID 12915427
  80. ↑ Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290(4):495-501 (2003) PMID 12876092
  81. ↑ Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289(4):454-65 (2003) PMID 12533125
  82. ↑ Analysis of cases of harm associated with use of health information on the internet. JAMA 287(21):2869-71 (2002) PMID 12038937
  83. ↑ Qualitative and quantitative measures of indexed health sciences electronic journals. JAMA 287(21):2865-6 (2002) PMID 12038935
  84. ↑ Comparison of review articles published in peer-reviewed and throwaway journals. JAMA 287(21):2853-6 (2002) PMID 12038932
  85. ↑ Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals. JAMA 287(21):2847-50 (2002) PMID 12038930
  86. ↑ Postpublication criticism and the shaping of clinical knowledge. JAMA 287(21):2843-7 (2002) PMID 12038929
  87. ↑ US legal principles and confidentiality of the peer review process. JAMA 287(21):2839-41 (2002) PMID 12038928
  88. ↑ Publication bias in editorial decision making. JAMA 287(21):2825-8 (2002) PMID 12038924
  89. ↑ Effects of technical editing in biomedical journals: a systematic review. JAMA 287(21):2821-4 (2002) PMID 12038923
  90. ↑ Association of journal quality indicators with methodological quality of clinical research articles. JAMA 287(21):2805-8 (2002) PMID 12038918
  91. ↑ Discussion sections in reports of controlled trials published in general medical journals. JAMA 287(21):2799-801 (2002) PMID 12038916
  92. ↑ Identifying manuscript reviewers: randomized comparison of asking first or just sending. JAMA 287(21):2795-6 (2002) PMID 12038915
  93. ↑ Prodding tardy reviewers: a randomized comparison of telephone, fax, and e-mail. JAMA 287(21):2794-5 (2002) PMID 12038914
  94. ↑ Author perception of peer review: impact of review quality and acceptance on satisfaction. JAMA 287(21):2790-3 (2002) PMID 12038913
  95. ↑ Measuring the quality of editorial peer review. JAMA 287(21):2786-90 (2002) PMID 12038912
  96. ↑ Effects of editorial peer review: a systematic review. JAMA 287(21):2784-6 (2002) PMID 12038911
  97. ↑ The hidden research paper. JAMA 287(21):2775-8 (2002) PMID 12038909
  98. ↑ Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA 287(21):2769-71 (2002) PMID 12038907
  99. ↑ Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287(5):612-7 (2002) PMID 11829700
  100. ↑ Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281(20):1900-5 (1999) PMID 10349893
  101. ↑ Freedom and responsibility in medical publication: setting the balance right. JAMA 280(3):300-2 (1998) PMID 9676691
  102. ↑ Ethical issues in studying submissions to a medical journal. JAMA 280(3):290-1 (1998) PMID 9676686
  103. ↑ The reported training and experience of editors in chief of specialist clinical medical journals. JAMA 280(3):286-7 (1998) PMID 9676684
  104. ↑ Reviewing the reviews: the example of chronic fatigue syndrome. JAMA 280(3):264-6 (1998) PMID 9676676
  105. ↑ Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German. JAMA 280(3):247-9 (1998) PMID 9676671
  106. ↑ US and non-US submissions: an analysis of reviewer bias. JAMA 280(3):246-7 (1998) PMID 9676670
  107. ↑ Masking author identity in peer review: what factors influence masking success? PEER Investigators. JAMA 280(3):243-5 (1998) PMID 9676669
  108. ↑ Does masking author identity improve peer review quality? A randomized controlled trial. PEER Investigators. JAMA 280(3):240-2 (1998) PMID 9676668
  109. ↑ Effect of blinding and unmasking on the quality of peer review: a randomized trial. JAMA 280(3):234-7 (1998) PMID 9676666
  110. ↑ What makes a good reviewer and a good review for a general medical journal? JAMA 280(3):231-3 (1998) PMID 9676665
  111. ↑ Reliability of editors' subjective quality ratings of peer reviews of manuscripts. JAMA 280(3):229-31 (1998) PMID 9676664
  112. ↑ Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342(25):1887-92 (2000) PMID 10861325
  113. ↑ Ethical complexities of conducting research in developing countries. N Engl J Med 337(14):1003-5 (1997) PMID 9309109
  114. ↑ Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337(8):536-42 (1997) PMID 9262498
  115. ↑ Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med 336(24):1722-9 (1997) PMID 9180090
  116. ↑ Sponsorship, authorship, and accountability. West J Med 175(4):259 (2001) PMID 11577056
  117. ↑ Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice. West J Med 174(4):262-5 (2001) PMID 11290685
  118. ↑ The peer review process. West J Med 151(5):561 (1989) PMID 2603425
  119. ↑ Occurrence and persistence of bacterial and viral faecal indicators in wastewater biofilms. Water Sci Technol 55(8-9):377-85 (2007) PMID 17547008
Abgerufen von „http://de.pluspedia.org/w/index.php?title=Aktuelle_Fragen_des_med.-wiss._Publikationswesens_(Teil_3)&oldid=951341“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway